SPIA
PRPH

Steward Partners Investment Advisory’s ProPhase Labs PRPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-290
Closed -$12.7K – 3552
2023
Q3 		$12.7K Sell
290
-60
-17% -$3.51K ﹤0.01% 2496
2023
Q2 		$25.4K Buy
+350
New +$28.5K ﹤0.01% 2175

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steward Partners Investment Advisory's PRPH Position: Q4 2023 in Review

Steward Partners Investment Advisory sold out of ProPhase Labs (PRPH) in Q4 2023, closing a stake of 290 shares — an estimated $12.7K sold.

Steward Partners Investment Advisory first reported a position in PRPH in Q2 2023 and held it in 2 quarters. The position peaked at $25.4K in Q2 2023. 27 funds tracked by Wall St. Rank hold PRPH as of Q4 2023.

  • Steward Partners Investment Advisory reported no remaining ProPhase Labs position as of Q4 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 290 ProPhase Labs shares in Q4 2023, an estimated $12.7K.
  • Steward Partners Investment Advisory first reported a position in ProPhase Labs in Q2 2023 and held it in 2 quarters.
  • Steward Partners Investment Advisory's ProPhase Labs position peaked at $25.4K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.